Viemed Healthcare Inc. (VMD)
NASDAQ: VMDHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
VMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $356.89M
- P/E (TTM)
- 26.03
- Forward P/E
- 23.43
- EPS (TTM)
- $0.36
- Dividend yield
- None
- 52-week range
- 6.05 – 12.61
- Day range
- 9.32 – 9.53
- Volume / Avg
- 366.63K / 354.36K
- Beta
- —
- Shares outstanding
- 38.09M
- Next earnings
- Nov 4, 2026
52-week range
VMD stock today
Viemed Healthcare (VMD) closed at $9.37 on Oct 7, up 0.43% (+$0.04), versus the S&P 500's 0.22% decline. Shares are 25.7% below their 52-week high of $12.61, set on Jul 13, 2026 and 54.9% above the 52-week low of $6.05, in the middle of the past year's range. VMD is up 26.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 36.4%.
At 26.0x trailing earnings, Viemed Healthcare trades above the peer-group median of 20.3x. Its forward P/E of 23.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Viemed Healthcare's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Viemed Healthcare
Company profileViemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Mr. Casey Hoyt
- Headquarters
- Lafayette, LA
- Employees
- 1,438
- Website
- viemed.com
Analyst forecast
ForecastConsensus (2 analysts)
buy
Avg. price target
$12.50+33.40%
- Strong buy 1
- Buy 0
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $0.12
Viemed Healthcare peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PARKPark Dental Partners Inc. | 20.94 | +1.26% | $99.58M | vs VMD |
| CCELCryo-Cell International Inc. | 3.91 | +0.77% | $31.52M | vs VMD |
| MGRXMangoceuticals Inc. | 0.4437 | -1.40% | $9.57M | vs VMD |
| NIVFNewGenIvf Group Limited Class A | 0.106 | +7.40% | $2.89M | vs VMD |
| AGLagilon health inc. | 85.70 | +2.76% | $1.44B | vs VMD |
| PGNYProgyny Inc. | 27.55 | +6.33% | $2.11B | vs VMD |
| SHCSotera Health Company | 17.90 | -1.92% | $5.11B | vs VMD |
| FMSFresenius Medical Care AG ADR | 20.69 | -7.72% | $11.01B | vs VMD |
Indexes, lists and sector
Viemed Healthcare stock FAQ
What is Viemed Healthcare's stock price today?
VMD last traded at $9.37 as of Oct 7, 4:00 PM EDT, up 0.43% on the day. Prices are delayed at least 15 minutes.
When is Viemed Healthcare's next earnings date?
Viemed Healthcare is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $0.12.
What is VMD's P/E ratio?
VMD trades at a trailing P/E ratio of 26.03 and a forward P/E of 23.43, compared with a median of 20.3 for its closest peers.
Who is Viemed Healthcare's CEO?
Mr. Casey Hoyt is the chief executive officer of Viemed Healthcare Inc., which has about 1,438 employees.
What is the VMD 52-week high?
The 52-week high for VMD is $12.61 and the 52-week low is $6.05. The stock is currently 25.7% below its high.